AlphAIalphai — Financial news for AI agents
SEC EDGAR 8-KAUG 64 min read$XZO

Exzeo Group, Inc. (XZO): Results of Operations and Financial Condition

Exzeo Group, Inc. (XZO) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 xzo-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Exzeo Announces Second Quarter 2026 Financial Results Managed Premium 1 of $1.40 billion; Pre-Tax Income of $31.4 million; Earnings per share 2 of $0.26 Tampa, Fla. - (BUSINESS WIRE) - August 6, 2026 - Exzeo Group, Inc. (NYSE:

Original reporting
SEC EDGAR 8-K
Published Aug 6, 2026, 8:19 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 8:27 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefEarnings
Primary signal
$XZO
Bullish
medium confidence
Mentioned
$XZO
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$XZOBullishMed
01

Why it matters

Traders can update near-term expectations for Exzeo’s platform traction using managed premium and annual recurring revenue, while monitoring margin and cash flow trends that reflect reinvestment.

02

Market read

Fresh quarterly operating and capital return metrics are likely to drive immediate sentiment and positioning ahead of the earnings call.

03

What to watch

Dependence on HCI Group for substantially all revenues is reiterated in the filing’s risk language, which can affect perceived earnings quality and valuation sensitivity.

Relevance 7/10Novelty 8/10Timing: after-hours filing on Aug 6, 2026, with conference call at 5:45 p.m. ET

Background

SEC 8-K Item 2.02 with Exhibit 99.1 press release covering Exzeo’s Q2 2026 financial results and operating metrics.

Company-level read

Ticker impact

$XZOBullishMedium confidence
Context

Exzeo reported Q2 2026 results with revenue $57.8M, managed premium $1.40B, and a $10.0M share repurchase during the quarter.

Expected impact

Near-term bias modestly positive, with traders likely focusing on managed premium and ARR trajectory versus the adjusted EBITDA margin decline.

Evidence & confidence

The filing provides fresh, company-specific operating metrics (managed premium, ARR) and capital return activity, but it does not include explicit forward guidance or a major surprise item beyond the reported quarter.

Market effects

Sector

Adds datapoint on P&C insurance software demand and carrier platform traction, relevant to insurtech sentiment.

Regional

Limited, company-specific disclosure with no stated regional macro driver.

Global

Low, US-listed issuer with no international deal or regulatory action mentioned.

Counterpoint

What could challenge this read

Adjusted EBITDA margin fell to 53% from 57%, and operating cash flow and free cash flow declined year over year, which could temper enthusiasm despite managed premium growth.

Key entities

  • issuer
    Exzeo Group, Inc.

    Reports Q2 2026 financial results, managed premium, ARR, adjusted EBITDA, and share repurchases; launches Exzeo Ventures for AI-native products.

  • executive
    Paresh Patel

    Chairman and CEO quoted on platform traction and the launch of Exzeo Ventures.

Read at source← All news

Related articles

MAY 27
$XZOMedAI 8/10

Exzeo Group (NYSE:XZO) CEO Acquires $26,520.00 in Stock

Exzeo Group CEO Paresh Patel bought 2,000 shares on May 26 at an average $13.26 each, totaling $26,520, according to an SEC filing. The purchase raised his stake to 1,670,013 shares. The article also notes Exzeo’s May 6 quarter results: EPS $0.22 (vs. $0.20 est.) and revenue $54.01M (vs. $55.90M est.), plus a $12M share repurchase authorization.

dailypolitical.com4 min
MAY 26
$XZOMedAI 8/10

Exzeo Group (NYSE:XZO) CEO Paresh Patel Acquires 2,000 Shares

Exzeo Group CEO Paresh Patel bought 2,000 shares of XZO on May 22 at an average $12.92, for $25,840, according to an SEC filing. The purchase raised his direct holding to 1,668,013 shares. The article also notes XZO traded around $13.44 Tuesday and last reported Q1 EPS of $0.22 vs $0.20 consensus on revenue of $54.01M vs $55.90M.

dailypolitical.com2 min
AUG 8
$LLYMedAI 8/10

Eli Lilly and Company Q2 Earnings Call Highlights

Eli Lilly (LLY) reported Q2 U.S. revenue up 33% led by ZEPBOUND and MOUNJARO volume, while U.S. price fell 3% (9% excluding rebate and discount estimate changes). International revenue rose in constant currency, with MOUNJARO a key driver. Lilly raised its 2026 revenue outlook to $85B-$87B and guided non-GAAP EPS $35.50-$36.50. It also discussed Medicare GLP-1 coverage expansion and retatrutide Phase III results.

yahoo.com7 min
AUG 8
$BRK-BMed

Berkshire Hathaway Just Did Something It Hasn’t Done in More Than 3 Years

Berkshire Hathaway reported Q2 2026 cash and Treasury bills of $365.5 billion, down from $397.4 billion in Q1, ending a 14-quarter streak as a net seller. According to Berkshire, CEO Greg Abel became a net buyer of equities, adding about $20 billion net, and increased buybacks to $4.5 billion. Apple fell to 20% of the portfolio; Alphabet rose after a $10 billion investment.

247wallst.com4 min
AUG 8
$LIONMed

Lionsgate Studios Q1 Earnings Call Highlights

Lionsgate (NYSE:LION) Q1 earnings call said it expects downstream revenue from films through fiscal 2027 and that The Hunger Games: Sunrise on the Reaping could support later-year results. Television revenue was $189 million, segment profit $10 million. Trailing 12-month library revenue was $987 million, backlog $1.5 billion. Net debt fell $121 million to about $1.5 billion; leverage improved to 4.3x.

yahoo.com6 min
AUG 8
$ENBMed

Enbridge Delivers Strong Q2 Results: Is the Stock Still a Buy?

Enbridge reported Q2 2026 results, with adjusted earnings of $1.4B, or $0.63 per share, roughly matching last year’s $0.65. Adjusted EBITDA rose to $4.8B from $4.6B. Operating cash flow increased to $4.1B from $3.2B. The company reaffirmed full-year guidance, added $1B to a $41B growth backlog, sanctioned Line 5 relocation and signed an option for the TTC Connector Pipeline.

baystreet.ca3 min
Exzeo Group, Inc. (XZO): Results of Operations and Financial Condition — alphai